The examination of sleep disoders in the patients with interstitial lung diseases
Not Applicable
- Conditions
- interstitial pneumonia
- Registration Number
- JPRN-UMIN000028242
- Lead Sponsor
- respiratory centor, Toranomon Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 125
Inclusion Criteria
Not provided
Exclusion Criteria
patients who have already diagnosed as sleep apnea syndrome
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method prevalence of sleep disorders and severity of QOL score in the patients with interstitial lung diseases at the beginning of the study, changes in QOL score by treating sleep apnea syndrome in the patients with interstitial lung diseases at 3,6,12,24 month after starting the study
- Secondary Outcome Measures
Name Time Method residual apnea-hypopnea index in the patients who took treatment of sleep apnea syndrome, prognosis, frequency of acute exacerbations of interstitial lung diseases at the point of 24 month after starting the study, changes in tricuspid valve regurgitation velocity by echocardiography at the point of 6 month after treatment of sleep apnea syndrome, changes in forced vital capacity and forced vital capacity percent predicted 6,12,24 after treatment